Discontinued — last reported Q3 '16
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)
Medtronic Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) increased by 0.1% to $1.35B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.1%, from $1.50B to $1.35B. Over 5 years (FY 2020 to FY 2025), Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) shows a downward trend with a -3.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
Detailed definition
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Peer comparison
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1Historical Data
| Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.58B | $1.59B | $1.59B | $1.59B | $1.59B | $1.59B | $1.57B | $1.57B | $1.58B | $1.48B | $1.49B | $1.50B | $1.35B | $1.35B | $1.35B |
| QoQ Change | — | +0.6% | -0.1% | -0.2% | +0.1% | +0.2% | -1.6% | +0.3% | +0.3% | -6.5% | +0.8% | +0.7% | -10.2% | +0.1% | +0.1% |
| YoY Change | — | — | — | +0.4% | -0.2% | +0.1% | -1.3% | -1.1% | -0.9% | -5.9% | -5.4% | -5.1% | -8.9% | -9.5% | -10.1% |
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) at Other Companies
Frequently Asked Questions
- What is Medtronic's finite-lived intangible assets - expected amortization expense (year one)?
- Medtronic (MDT) reported finite-lived intangible assets - expected amortization expense (year one) of $1.35B in Q1 2026.
- How has Medtronic's finite-lived intangible assets - expected amortization expense (year one) changed year-over-year?
- Medtronic's finite-lived intangible assets - expected amortization expense (year one) decreased by 10.1% year-over-year, from $1.50B to $1.35B.
- What is the long-term trend for Medtronic's finite-lived intangible assets - expected amortization expense (year one)?
- Over 5 years (2020 to 2025), Medtronic's finite-lived intangible assets - expected amortization expense (year one) has grown at a -3.6% compound annual growth rate (CAGR), from $1.62B to $1.35B.
- What does finite-lived intangible assets - expected amortization expense (year one) mean?
- The expected non-cash expense for amortizing intangible assets over the next twelve months.